Neuland Laboratories RSI
What is the RSI of Neuland Laboratories?
The RSI of Neuland Laboratories Limited is 75.73
What is the definition of RSI?
The relative strength index (RSI 14) is a momentum indicator that compares the magnitude of gains and losses over a specified time period to measure speed and change of price movements of a security.
14-day period
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI of companies in the Health Care sector on BSE compared to Neuland Laboratories
What does Neuland Laboratories do?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Companies with rsi similar to Neuland Laboratories
- Diversicare Healthcare Services Inc has RSI of 75.68
- Cohen & Steers Total Return Realty Fund Inc has RSI of 75.68
- TD Q U.S. Low Volatility ETF has RSI of 75.69
- Merck KGaA has RSI of 75.69
- Religare Enterprises has RSI of 75.69
- Container Store Inc has RSI of 75.69
- Neuland Laboratories has RSI of 75.73
- New America High Income Fund Inc has RSI of 75.74
- Labixiaoxin Snacks has RSI of 75.75
- Majesco has RSI of 75.76
- Mesabi Trust has RSI of 75.76
- Majesco has RSI of 75.76
- Kaleyra Inc has RSI of 75.76